Document Detail


A novel peroxynitrite decomposer catalyst (FP-15) reduces myocardial infarct size in an in vivo peroxynitrite decomposer and acute ischemia-reperfusion in pigs.
MedLine Citation:
PMID:  12400769     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Reactive oxygen and nitrogen species generated after reperfusion injury result in organ dysfunction. Peroxynitrite, a reactive nitrogen molecule produced from the reaction of superoxide anions and nitric oxide, is thought to be a causative agent in oxidative reperfusion injury. The aim of this study was to investigate the effects of a novel peroxynitrite decomposition catalyst (FP-15) in an acute myocardial ischemia/reperfusion model.
METHODS: Pigs were subjected to 60 minutes of regional ischemia by reversibly ligating the left anterior descending coronary artery followed by 180 minutes of reperfusion. In the treatment group (n = 6), an FP-15 (1 mg/kg) bolus was infused through the jugular vein after 30 minutes of ischemia followed by a continuous infusion (1 mg x kg(-1) x h(-1)) during reperfusion. Vehicle was infused in the control group (n = 6). Coronary flow was recorded by an ultrasonic flow probe and infarct size determined by tetrazolium staining. Arterial and left ventricular pressures were monitored continuously and regional myocardial function determined by sonomicrometry.
RESULTS: No significant differences were observed in either hemodynamics or ischemic area at risk. However, the infarct size was significantly reduced (35.3% +/- 3.5% versus 21.6% +/- 2.6% of the ischemic area, control versus FP-15-treated groups, respectively, p < 0.05). +dP/dt was transiently improved in the FP-15-treated groups while during most of the reperfusion period coronary flow, and was significantly lower in the FP-15-treated group as compared to the control group (p < 0.01).
CONCLUSIONS: FP-15 administration reduces myocardial infarct size and reactive hyperemia. These data support the pathogenic role of endogenously produced peroxynitrite and that FP-15 is effective in preventing myocardial reperfusion injury.
Authors:
Cesario Bianchi; Hidetaka Wakiyama; Renato Faro; Tanveer Khan; James D McCully; Sidney Levitsky; Csaba Szabó; Frank W Sellke
Related Documents :
20931339 - Autophagy in myocardium of murine hearts subjected to ischemia followed by reperfusion.
15240959 - Do indices of coronary conductance after reperfusion reflect the extent of salvaged myo...
10402449 - Relationship of elevated 23na magnetic resonance image intensity to infarct size after ...
9774189 - Ischemic preconditioning and superoxide dismutase protect against endothelial dysfuncti...
719659 - Regional myocardial energetics during brief periods of coronary occlusion and reperfusi...
8461519 - Models of myocardial stunning.
7475129 - The role of coronary revascularization in recipients of an implantable cardioverter-def...
21486629 - Ventricular assist system applications in end-stage heart failure.
7198469 - Reperfusion effects on the magnesium-procaine arrested rabbit heart.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  74     ISSN:  0003-4975     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  2002 Oct 
Date Detail:
Created Date:  2002-10-28     Completed Date:  2002-11-26     Revised Date:  2013-04-30    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1201-7     Citation Subset:  AIM; IM    
Affiliation:
Division of Cardiothoracic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Coronary Circulation / drug effects
Disease Models, Animal
Female
Male
Myocardial Infarction / pathology*
Myocardial Reperfusion Injury / metabolism*,  physiopathology,  prevention & control
Peroxynitrous Acid / metabolism*
Swine
Grant Support
ID/Acronym/Agency:
R01 HL-46716/HL/NHLBI NIH HHS; R01 HL029077/HL/NHLBI NIH HHS; R43 HL-65863/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
14691-52-2/Peroxynitrous Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A retrospective review of three antibiotic prophylaxis regimens for pediatric cardiac surgical patie...
Next Document:  Effects of hypothermia on myocardial substrate selection.